4.4 Article

Distribution of Nicotinamide Mononucleotide after Intravenous Injection in Normal and Ischemic Stroke Mice

Journal

CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Volume 24, Issue 2, Pages 299-309

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389201023666220518113219

Keywords

Nicotinamide mononucleotide; nicotinamide adenine dinucleotide; distribution; ischemic stroke; therapeutic effect; acute toxicity

Ask authors/readers for more resources

This study investigated the distribution of intravenous NMN in normal and ischemic stroke mice, its therapeutic effect on ischemic brain infarction, and the acute toxicity after injection. The results showed that NMN can distribute to various tissues, enter the brain to boost NAD levels, and exhibit therapeutic effect without acute toxicity. The kidney was found to have the highest distribution of NMN.
Objective This study determined for the first time the distribution of intravenous nicotinamide mononucleotide (NMN) and its metabolite nicotinamide adenine dinucleotide (NAD) in normal and ischemic stroke mice, examined the therapeutic effect of NMN on ischemic brain infarction, and evaluated acute toxicity of NMN after intravenous injection of NMN. Methods NMN and NAD levels were determined using ultra-high-performance liquid chromatography tandem mass spectrometry in biological samples from mice with or without middle cerebral artery occlusion (MCAO) at different time points post intravenous NMN injection (300 mg/kg). Brain infarction was evaluated 24 h post-MCAO. 2 g/kg NMN was used in the acute toxicity test. Results Under either normal or MCAO conditions, serum NMN levels sharply increased after intravenous NMN administration and then decreased rapidly within 15 min, while serum NAD levels remained unchanged during 30 min observation. Both substances displayed tissue accumulation over time and stored faster under MCAO conditions, with kidney having the highest concentrations. Particularly, NMN accumulated earlier than NAD in the brain. Moreover, NMN reduced cerebral infarction at 24 h post-MCAO. No acute toxicity was observed for 14 days. NRK1 and SLC12A8 involved in two pathways of NMN uptake exhibited the highest expressions in kidney and colon, respectively, among 11 different tissues. Conclusion NMN distributes to various tissues after intravenous injection and has the ability to enter the brain to boost NAD levels, and exhibits safety and therapeutic effect on acute ischemic stroke injury. High renal distribution of NMN indicates its importance in the kidney.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available